Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study

Posted on | Posted on John Murphy | Leave a Comment on Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study

Authors: Deepalakshmi Kaliyaperumal,1Kumar Bhargavi,2Karthikeyan Ramaraju,3Krishna S Nair,4Sudha Ramalingam,5 and Murali Alagesan6 Indian J Crit Care Med. 2022 Jan; 26(1): 43–48.doi: 10.5005/jp-journals-10071-24045PMCID:  PMC8783240PMID: 35110843 Abstract Background Coronavirus disease-2019 (COVID-19) infection is a multisystem disease not restricted to the lungs. It has a negative impact on the cardiovascular system by causing myocardial damage, vascular inflammation, plaque instability, and myocardial infarction. The presence […]

Five months post-covid, Nicole Murphy’s heart rate is still doing strange things

Posted on | Posted on John Murphy | Leave a Comment on Five months post-covid, Nicole Murphy’s heart rate is still doing strange things

Authors: Ariana Eunjung Cha February 21, 2022 Five months after being infected with the coronavirus, Nicole Murphy’s pulse rate is going berserk. Normally in the 70s, which is ideal, it has been jumping to 160, 170 and sometimes 210 beats per minute even when she is at rest — putting her at risk of a […]

Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination

Posted on | Posted on John Murphy | Leave a Comment on Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination

Authors: Aneel A. Ashrani, MD, MS1; Daniel J. Crusan, BS2; Tanya Petterson, MS2; et al JAMA Intern Med. 2022;182(1):80-83. doi:10.1001/jamainternmed.2021.6352 Recent reports1–4 suggest a possible association between Ad26.COV2.S (Johnson & Johnson/Janssen) COVID-19 vaccination and cerebral venous sinus thrombosis (CVST). Estimates of postvaccination CVST risk require accurate age- and sex-specific prepandemic CVST incidence rates; however, reported rates vary widely.5 We compared the age- and sex-specific CVST rates after […]

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

Posted on | Posted on John Murphy | Leave a Comment on Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

The I-TECH Randomized Clinical Trial Authors: Steven Chee Loon Lim, MRCP1; Chee Peng Hor, MSc2,3; Kim Heng Tay, MRCP4; et al JAMA Intern Med. Published online February 18, 2022. doi:10.1001/jamainternmed.2022.0189 Key Points Question  Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities? Findings  In this open-label randomized clinical trial […]

Mystery of the missing workers? Long COVID a big piece of the puzzle

Posted on | Posted on John Murphy | Leave a Comment on Mystery of the missing workers? Long COVID a big piece of the puzzle

Authors: Michael E. Kanell, The Atlanta Journal-Constitution Feb 19, 2022 She suffered cardiac arrest twice and was in the hospital for three months, then came home to more than a year of kidney problems and intermittent brain fog, tingling in her hands, numbness in her right foot and a need for oxygen after even modest […]

Gastrointestinal perforation secondary to COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Gastrointestinal perforation secondary to COVID-19

Case reports and literature review Authors: Reem J. Al Argan, MBBS, SB-Med, SF-Endo, FACE, ECNU,∗Safi G. Alqatari, MBBS, MRCPI, MMedSc, CFP (Rheum), Abir H. Al Said, MBBS, SB-Med, CFP (Pulmo.), Raed M. Alsulaiman, MBBS, SB-Med, Abdulsalam Noor, MBBS, SB-Med, ArBIM, SF-Nephro, Lameyaa A. Al Sheekh, MD, SB-med, and Feda’a H. Al Beladi, MD Abstract Introduction: Corona virus disease-2019 (COVID-19) presents […]

Abdominal Pain and Diffuse Colitis Following COVID-19 Infection: Report of a Case

Posted on | Posted on John Murphy | Leave a Comment on Abdominal Pain and Diffuse Colitis Following COVID-19 Infection: Report of a Case

Authors: Rouzbeh ShadidiAsilaSetarehMahmoodiaAmirZamaniaAzadehHakakzadehbcElenaJamalid International Journal of Surgery Case Reports Volume 8, November 2021, 106473 Highlights • Patients with COVID-19 sometimes presents with GI symptoms in addition to respiratory symptoms.• Detecting RNA of SARS-CoV-2 in the stool specimen of the patient with COVD-19 has raised the concern of fecal-oral transmission of the virus.• Invasion of the virus […]

HOW COVID-19 AFFECTS THE GUT: SCIENTISTS UNCOVER A RARE SIDE EFFECT

Posted on | Posted on John Murphy | Leave a Comment on HOW COVID-19 AFFECTS THE GUT: SCIENTISTS UNCOVER A RARE SIDE EFFECT

Authors: published on The Conversation by Vincent Ho at Western Sydney University. Although we might think of Covid-19 as a respiratory disease, we know it involves the gut. In fact, SARS-CoV-2, the virus that causes Covid-19, enters our cells by latching onto protein receptors called ACE2. And the greatest numbers of ACE2 receptors are in the cells that line the gut. […]

Pfizer BioNTech Covid Vaccine and Ovarian cysts – a phase IV clinical study of CDC and FDA data

Posted on | Posted on John Murphy | Leave a Comment on Pfizer BioNTech Covid Vaccine and Ovarian cysts – a phase IV clinical study of CDC and FDA data

Summary: Ovarian cysts is found among people who get Pfizer BioNTech Covid Vaccine, especially for people who are 30-39 old, and after 30 days of getting the vaccine. The phase IV clinical study analyzes which people get Pfizer BioNTech Covid Vaccine and have Ovarian cysts. It is created by eHealthMe based on reports of 286,220 […]